Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Vadim Alexandre | Liam Gascoigne-Cohen
3 pages
Synairgen (SNG.L): Completion of recruitment of hospitalised patients in Covid-19 Trial | Oncimmune Holdings (ONC.L): Contract Signed with Roche | N4 Pharma (N4P.L): Covid-19 Project Update
Companies: SYGGF 4BB ACSO PRM SUN AMS ARBB SN/ EKF EAH SAR TSTL IPO HAT CNSL SDI TRX SCLP HVO CTEC FAB SBTX POLX VLG IXI VAL SPI INDV PHP STX CREO SYNC APAX AREC ONT SLN IMCR ABDX
Companies: SYGGFTUINSDYXARPRMSGMMEGPAGLAGYEMRTSTLCTHCNSLTCGSFRSDIDOTDBVXPCOGYGENABZAOPTIGLEMTFBIHCOTBSTXRTHMAVCTLDRUFDVLAKR
Companies: TXG SYGGF Z29 TXG FARN 4BB PRM SUN AMS SN/ OMG EKF EAH SAR TSTL IPO CNSL SDI TRX SCLP HVO CTEC FAB SBTX POLX VLG IXI VAL SPI INDV PHP STX CREO SYNC AREC ONT SLN IMCR ABDX
Companies: SYGGFPRMHEADIOMAGYEMRTSTLCTHPHDCNSLVANQSDIBVXPINSECOGFDEVYGENABZAEPWNOPTISPEMTFBIHCAVCTLDRUFDVLWX1
Companies: Synairgen plc
